Search for Clinical Trial Results
Choroid Diseases - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization Condition: Choroidal Neovascularization Date: 2016-08-21 Interventions: Drug: 0.5mg intravitreal ranibizumab Patients received ranibizumab (0.5mg, Novartis AG, Basel, Switzerla |
Recruiting |
Study Name: Intravitreal Conbercept for Idiopathic Choroidal Neovascularization Condition: Idiopathic Choroidal Neovascularization Date: 2016-07-27 Interventions: Drug: conbercept 0.05ml conbercept Other Name: conbe |
Recruiting |
Study Name: Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA). Condition: Inflammatory Choroidal Neovascularization Date: 2015-09-18 Interventions: Drug: Aflibercept The patients are followed on a monthly basis until 52 weeks. Intravitreal injections o |
Recruiting |
Study Name: Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3) Condition: Type 3 Choroidal Neovascularization Date: 2014-12-10 Interventions: Drug: Aflibercept |
Recruiting |
Study Name: Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization Condition: Choroidal Neovascularization Date: 2014-10-06 Interventions: Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) Administration by intravitreal injection |